Sensitivity and specificity of SLE classification criteria following the stratification for sex, age and disease duration
| Sensitivity | Specificity | |||||
| ACR-1997 | SLICC-2012 | EULAR/ACR-2019 | ACR-1997 | SLICC-2012 | EULAR/ACR-2019 | |
| Sex | ||||||
| Female | 82.0% | 98.1% | 98.1% | 95.0% | 90.7% | 89.6% |
| Male | 83.3% | 100.0% | 90.0% | 100.0% | 96.2% | 96.2% |
| Age | ||||||
| <40 years | 81.5% | 98.0% | 97.5% | 95.5% | 93.2% | 90.9% |
| ≥40 years | 82.4% | 98.6% | 97.3% | 96.6% | 91.9% | 91.6% |
| Disease duration | ||||||
| ≤1 year | 78.6% | 100.0% | 100.0% | – | – | – |
| 1–≤3 years | 81.8% | 100.0% | 100.0% | – | – | – |
| 3–≤5 years | 81.6% | 100.0% | 100.0% | – | – | – |
| >5 years | 83.7% | 97.1% | 95.7% | – | – | – |
ACR, American College of Rheumatology; EULAR, European Alliance of Associations for Rheumatology; SLICC, Systemic Lupus International Collaborating Clinics.